According to Mr. Adar Poonawalla, CEO, Serum Institute of India (SII) stated that they could export 20 million to 30 million doses of the AstraZeneca shot to the WHO-backed global platform COVAX this year and then several more from January.
Mr. Adar Poonawalla stated that the company's production of the vaccine could rise to 240 million doses a month from ~ 220 million currently. He also added that SII will make only the single-dose Sputnik Light vaccine from Russia and not the two-dose Sputnik V.
SII could also produce 50 million to 100 million doses of the Novavax vaccine by December, Mr. Poonawalla added further.
Disclaimer: This information has been collected through secondary research and IBEF is not responsible for any errors in the same.